{
    "clinical_study": {
        "@rank": "18484", 
        "acronym": "PERINE", 
        "arm_group": [
            {
                "arm_group_label": "study group (cohort PELAGIE)", 
                "arm_group_type": "Experimental", 
                "description": "100 children included in the cohort PELAGIE"
            }, 
            {
                "arm_group_label": "pilot group (no cohort PELAGIE)", 
                "arm_group_type": "Experimental", 
                "description": "10 children not included in the PELAGIE cohort to optimise MRI"
            }
        ], 
        "brief_summary": {
            "textblock": "This project aims at evaluating the consequences of prenatal exposure to neurotoxicants\n      (solvents, organophosphate pesticides) on the developing brain, in children aged from 10 to\n      12 years."
        }, 
        "brief_title": "PERINE : Effect of Prenatal Exposure to Neurotoxicants on the Developing Brain : an MRI Study", 
        "condition": "Effects of Neurotoxicants on the Brain", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children included in the cohort PELAGIE\n\n          -  Children participated in the study PEPSY\n\n          -  Age between 10 and 12 years (pilot study)\n\n        Exclusion Criteria:\n\n          -  Maternal smoking and or alcohol consumption during pregnancy (study group)\n\n          -  Children with a health event affecting neurodevelopment\n\n          -  Children treated with methylphenidate, psychotropic or anti-epileptics"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "12 Years", 
            "minimum_age": "10 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02125110", 
            "org_study_id": "2013-A01420-45"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "study group (cohort PELAGIE)", 
                    "pilot group (no cohort PELAGIE)"
                ], 
                "intervention_name": "MRI", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "study group (cohort PELAGIE)", 
                "intervention_name": "neuropsychological assessment", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "neurotoxicants", 
            "MRI", 
            "developing brain"
        ], 
        "lastchanged_date": "April 24, 2014", 
        "location": {
            "contact": {
                "last_name": "Fabienne FP Pel\u00e9"
            }, 
            "facility": {
                "address": {
                    "city": "Rennes", 
                    "country": "France"
                }, 
                "name": "CHU Rennes"
            }, 
            "investigator": {
                "last_name": "Fabienne FP Pel\u00e9", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Prenatal Exposure to Neurotoxicants on the Developing Brain: an MRI Study", 
        "overall_contact": {
            "email": "fabienne.pele@chu-rennes.fr", 
            "last_name": "Fabienne FP Pel\u00e9", 
            "phone": "33-2-9928-9302"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measurement of the fractional anisotropy of the regions of interest on MRI :\n- with DTI (Diffusion Tensor Imaging) : DTI can be used to generate quantitative maps of the scalar (anisotropy, based on measurements of FA and mean diffusivity (MD)) or tensor (diffusivity expressed in the form of a 3x3 matrix) type. An intergroup analysis will be carried out to identify regions with FA and MD values different between exposed and non-exposed subjects. Tractography of the fibre bundles in the white matter could also be carried out, based on regions of interest extracted, for example, from high resolution morphometry or functional activation maps. The connectivity between these different regions may also be studied.", 
            "measure": "Measurement of the brain activity and its functionality", 
            "safety_issue": "No", 
            "time_frame": "day 1"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02125110"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measurement of the cerebral blood flow and the activation of the regions of interest on MRI with :\nBOLD-fMRI (Blood Oxygen Level Dependent) : detection of the voxels activated, for each child, during the tasks (motor inhibition (Go / No-Go), attention (Posner's task) and working memory (N-back)) and comparison of levels of brain activation between exposure groups\nASL (Arterial Spin Labeling) : quantitative value for cerebral blood flow", 
                "measure": "Measurement of the brain activity and its functionality", 
                "safety_issue": "No", 
                "time_frame": "day 1"
            }, 
            {
                "description": "Correlation between the results of neuropsychological tests (subtests of the NEPSY (developmental NEuroPSYchological assessment) and the WISC-IV (Wechsler Intelligence Scale for Children version IV) tests that will evaluate motor inhibition, attention, working memory and graphomotor capacities) and MRI measurement", 
                "measure": "Results of neuropsychological tests", 
                "safety_issue": "No", 
                "time_frame": "day 1"
            }
        ], 
        "source": "Rennes University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rennes University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}